This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. To initiate infection, equine herpesvirus type 1 (EHV-1) attaches to heparan sulfate on cell surfaces and then 33 interacts with a putative glycoprotein D receptor(s). After attachment, virus entry occurs either by direct fusion 34 of the virus envelope with the plasma membrane or via endocytosis followed by fusion between the virus 35 envelope and an endosomal membrane. Upon fusion, de-enveloped virus particles are deposited into the 36 cytoplasm and travel to the nucleus for viral replication. In this report, we examined the mechanism of EHV-1 37 intracellular trafficking and investigated the ability of EHV-1 to utilize specific cellular components to 38 efficiently travel to the nucleus post-entry. Using a panel of microtubule depolymerizing drugs and inhibitors of 39 microtubule motor proteins, we show that EHV-1 infection is dependent on both the integrity of the microtubule 40 network and the minus-end microtubule motor protein, dynein. In addition, we show that EHV-1 actively 41 induces the acetylation of tubulin, a marker of microtubule stabilization, as early as 15 minutes post-infection. 42
Introduction 47
Equine herpesvirus 1 (EHV-1) is a major pathogen of horses. Most horses are exposed to the virus within 6 48 months to a year after birth and are frequently re-infected throughout their lifetime (Allen, 1986) . Clinical signs 49 that appear early after infection include fever, inappattence, malaise, coughing, and mucopurulent discharge 50 (O'Callaghan et al., 1983) . As the infection progresses, horses may exhibit signs of serious neurological illness 51 including ataxia, disorientation, and partial to full paralysis. In addition to the neurological sequelae, EHV-1 52 also causes abortigenic disease in pregnant mares. In this study, we show that EHV-1 causes the stabilization of microtubules via the acetylation of tubulin and 90 utilizes the minus-end directed microtubule motor dynein to traffic to the nucleus along stabilized microtubules. 91
In addition, we show that nuclear accumulation of capsids is decreased in the presence of the ROCK1 inhibitor, 
Drug inhibition assays 09
M a n u s c r i p t 5 For entry assays, 2.5 x 10 4 ED or CHO-K1 cells were seeded in a 96-well plate. The next day, cells were 10 incubated with increasing amounts of the microtubule depolymerizing drugs, nocodazole, vinblastine, 11 colchicine, the microtubule stabilizing drug, paclitaxel (PTX), the dynein inhibitor, EHNA (erythro-9-(2-12 hydroxy-3-nonyl) adenine, or the kinesin inhibitor AMP-PNP (adenosine 5-(, -imido) triphosphate 13 tetralithium salt) (Sigma, St. Louis, MO) at 37C for 30 min. Cells were infected with EHV-1 (L11gIgE) at 14 an MOI of 5 and incubated for 5.5 h in the presence of the drugs at 37C. Cells were washed once with PBS and 15 then ONPG was added to the cells and the absorbance read at 405nm. Confluent ED cells in a 12-well plate were serum starved for 1 h and cells were then mock-treated or treated 26 with paclitaxel (10 M) or Y-27632 (100 M). Cells treated with paclitaxel were washed with MEM at 15, 30, 27
and 60 min and cell lysates were harvested with PARP lysis buffer (6 M urea, 2% SDS, 10% glycerol, 62.5 mM 28
Tris-HCl, pH 6.8, and 5% -mercaptoethanol). were run on a 10% SDS-PAGE gel and transferred to an immobilon-P membrane (Millipore, Billerica, MA). 32
The membranes were blocked for 1 h in 10% non-fat dry milk (NFDM) at room temperature (RT) before 33 monoclonal anti-acetylated tubulin antibody 6-11B-1 (Sigma) was added at a concentration of 1:2000 in TBST 34
with 5% NFDM for 16 h at 4C. The membranes were washed 3x for 10 min/wash and then anti-mouse-HRPM a n u s c r i p t 6 antibody SC-2031 (Santa Cruz Biotechnology, Santa Cruz, CA) was added at a concentration of 1:3,000 in 36 TBST with 5% NFDM for 1 h at RT. Membranes were washed 3x for 10 min/wash then ECL detection reagent 37 (Amersham Biosciences, Buckinghamshire, England) was added and the membranes exposed to film. After 38 stripping the membrane with stripping buffer (10% SDS, 0.5M Tris pH 6.8, 0.5% -mercaptoethanol) for 30 39 min at 50C, the membranes were washed 2x for 10 min/wash with TBST and then blocked for 1 h with 10% 40 NFDM. Total tubulin was detected by adding monoclonal anti--tubulin antibody B-5-1-2 (Sigma) at 1:2,000 41
for 16 h at 4C with the secondary antibody and detection steps as described earlier. was not the result of drug-associated cell toxicity as cell viability was similar for all of the concentrations used. 78
In addition to inhibiting infection on ED cells, these drugs also inhibited infection on CHO-K1 cells (data not 79 shown). These results indicate that an intact microtubule network is required regardless of the mode of EHV-1 80
entry. 81
To address the importance of microtubule dynamics or treadmilling (polymerization/depolymerization of 82 microtubules) in virus transport, microtubules were first stabilized with paclitaxel or left untreated before and 83 during infection with EHV-1. Virus entry was assessed by measuring -galactosidase activity 5.5 h post-84 infection. In both ED (Fig 2A) and CHO-K1 (Fig 2B) cells, stabilization of microtubules prior to the addition of 85 EHV-1 had no effect on infection as measured by viral reporter gene expression. To assure that paclitaxel 86 treatment of ED cells induced microtubule stabilization, we examined the acetylation of tubulin, which has been was added and allowed to attach to the cells at 4C for 2 hours to synchronize the entry process. After 97 attachment, medium warmed to 37C, with or without addition of the drug, was added to the cells to allow 98 infection to ensue. At 0 and 60 minutes post-temperature shift, cells were stained with Hoechst dye and wheat 99 germ agglutinin to label the nucleus (blue) and plasma membrane (green), respectively. As shown in Figure 4 , 00 attached virus (red) was detected on the surface of mock-treated and paclitaxel-treated cells at the 0 time-point. 01
At the 60-minute time-point, a similar number of capsids were observed at the nucleus in both mock-treated and 02 paclitaxel-treated cells. The ability of virus to reach the nucleus after paclitaxel stabilization of microtubules in 03 a manner similar to that observed in mock-treated cells suggests that EHV-1 is efficiently transported along 04 stable microtubules and that there is not a requirement for a continuous process of microtubule 05 polymerization/depolymerization (treadmilling) for successful delivery of EHV-1 to the nucleus. 06 07
EHV-1 infection induces the acetylation of tubulin 08
The ability of EHV-1 to traffic along stable microtubules led us to ask whether EHV-1 actively induces the inhibitor had no effect on the ability of EHV-1 to cause the acetylation of tubulin. These results indicate that 20 EHV-1 actively induces the acetylation of microtubules and that this process is not dependent upon the 21 activation of ROCK1. 22 23
The microtubule motor, dynein, is essential for EHV-1 infection 24
Dynein is a minus-end directed motor that transports intracellular cargo along microtubules and many The inhibition of EHV-1 infection by EHNA indicates that EHV-1 utilizes dynein for movement to the nucleus 35 post-entry. 36
Since the initial entry process of EHV-1 in CHO-K1 cells is different from entry into ED cells, we asked 37 whether dynein was also employed for intracellular movement of EHV-1 in CHO-K1 cells. Entry of EHV-1A c c e p t e d M a n u s c r i p t into CHO-K1 cells was also inhibited by EHNA in a dose-dependent manner (Fig 6B) . These data suggest that, 39 while the initial entry of EHV-1 into different cell types is dissimilar, the virus uses the same molecular 40 machinery for transport post-entry. 41 42
Inhibition of ROCK1 deregulates the intracellular processing of EHV-1 43
In a previous study, we showed that the activation of ROCK1 is critical for productive EHV-1 infection 44 (Fig. 8 ). Cells were untreated (Fig. 8A) or treated with Y-27632 (Fig. 8B) for 30 minutes at 37C and 64 then virus was added and allowed to attach to cells for 2 hours at 4C. After the attachment period, cells were 65 warmed to 37C to allow for virus entry. Infected cells were fixed and imaged at 0 to 120 minutes post-66 temperature shift using a confocal microscope. At the 0 time-point, virus particles were attached to the plasma 67 membrane (yellow circles) and no particles were observed inside either the untreated or Y-27632-treated cells. 68
At 15 minutes post-infection, internal and external virus particles were observed in both groups. Interestingly, 69 as shown in Figure 8A about one-third of the virus particles were localized to the nucleus in the mock-treated 70 cells (white circles) at 15 minutes post-infection, but only two virus particles were observed at the nucleus in 71 the Y-27632-treated cells (Fig. 8B) . Over the course of infection, more virus particles accumulated at the 72 nucleus in the untreated cells ( of these cellular motors for transport, viruses would never be able to find their way through the dense and 85 intricate cytoskeletal structures and would thus fail to replicate and release progeny virus. 86
In this study, we show that EHV-1 utilizes the microtubule network and the minus-end directed motor 87 protein dynein to productively infect cells. Disruption of the microtubular network with the microtubuleM a n u s c r i p t depolymerizing agents nocodazole, vinblastine, and colchicine inhibited the ability of EHV-1 to productively 89 infect cells and deliver its payload to the nucleus. In addition, the introduction of dynein, but not kinesin 90 inhibitors, also reduced infection. Interestingly, microtubules and dynein were required for virus trafficking in 91 cells that were infected via an endocytic route or by direct fusion of virus at the plasma membrane. These data 92 suggest at least two possible models for intracellular trafficking of EHV-1 particles that we have designated as 93 the direct and the indirect trafficking model. In the direct model, nucleocapsids that are still surrounded by some 94 tegument proteins would bind to dynein via a viral capsid or tegument protein and this event would therefore 95 occur only after completion of the fusion event between the viral envelope and either the plasma or endosomal 96 membrane. In the indirect model, EHV-1 would be transported within an endosome and an endosomal protein 97 or complex would interact with dynein. Virus would then fuse and be released from the endosome once it is in 98 close proximity to the nucleus. The ability of EHV-1 to enter some cells by direct fusion at the cell membrane 99 implies that a direct interaction between a viral protein and a dynein component most likely has to occur for the 00 virus to traffic to the nucleus. However, since EHV-1 enters other cell types via an endocytic mechanism, it is 01 possible that the indirect model of trafficking applies in these cells and thus the mechanism of intracellular 02 movement of virus toward the nucleus may be cell-type dependent. Studies are currently underway using 03 L11VP26mRed in conjunction with dynein and endosomal marker antibodies to further explore these models. 04
An intriguing finding from this study is the importance of the Rho kinase, ROCK1, for intracellular 05 trafficking of EHV-1 particles. Previously, we showed that inhibition of this kinase significantly reduced EHV-06 1 infection (Frampton et al., 2007), but we did not address the mechanism. In the current study, we showed that 07 treatment with a ROCK1 inhibitor significantly decreased the number of capsids that accumulated at the 08 nucleus suggesting a role for ROCK1 in the intracellular trafficking of EHV-1. 09
While this is the first report to connect ROCK1 activation with virus trafficking, previous studies have 10
shown that other molecules involved in the ROCK1 signaling pathway also contribute to virus movement 11 within cells. Naranatt and colleagues reported that inactivation of the RhoA GTPase, which acts directly for HSV-1 capsid trafficking. The finding in our current study that EHV-1 infection actively induces the 23 stabilization of microtubules and that infection is not negatively affected by the prior stabilization of 24 microtubules suggests a common mechanism of microtubule transport of nucleocapsids that is shared amongst 25
alphaherpesviruses. 26
The connection between EHV-1-induced microtubule stabilization, virus trafficking along stabilized 27 microtubules, and the dependence of virus trafficking on ROCK1 function would suggest a direct role for the 28
RhoA-ROCK1 signaling pathway in microtubule stabilization. However, one group showed that while RhoA is 29 required for this effect, it is not mediated through ROCK1 (Palazzo et al., 2001 ). Consistent with these data, our 30 results revealed that the inhibition of EHV-1 infection by Y-27632 did not inhibit EHV-1-induced stabilization 31 of microtubules. We therefore concluded that the contribution of ROCK1 to virus trafficking is most likely 32 separate from virus-induced microtubule stabilization. 33
The observation that many virus particles remain associated with the plasma membrane in the presence of 34 the ROCK1 inhibitor Y-27632 suggests other possible roles for ROCK1 in virus trafficking. Two intriguing 35 possibilities are that 1) ROCK1 activity is required in order to mediate an interaction between virus and 36 microtubules and/or other cytoskeletal components or 2) ROCK1 is required for efficient fusion of the viral 37 envelope with a cellular membrane. Inhibition of either of these processes could account for the inability of 38 EHV-1 to traffic to the nucleus. Future studies will examine which virus components are involved in theM a n u s c r i p t 14 initiation of signaling pathways that lead to both ROCK1 activation and separately the acetylation of 40
microtubules. 41 42

Conclusion 43
In the current study we examined some of the early interactions between EHV-1 and host cell factors and, in 44 particular, investigated how EHV-1 utilizes the cell's microtubular network and associated proteins to 45 efficiently infect susceptible cells. Our results showed that disruption of microtubules by the addition of 46 microtubule-depolymerizing agents and the inhibition of the microtubule motor protein, dynein, significantly 47 abrogated EHV-1 infection in ED and CHO-K1 cells. Our data also revealed that stabilization of microtubules 48 by paclitaxel prior to infection had no impact on the efficiency of EHV-1 infection in either cell type. 49
Interestingly, our data showed that microtubules are acetylated very early after infection with EHV-1. Whether 50 this acetylation is an absolute requirement for EHV-1 infection is an intriguing question and efforts are 51 underway to address this possibility. Finally, we showed that inhibition of the cellular kinase ROCK1 with the 52 drug Y-27632, inhibited the movement of EHV-1 capsids to the nucleus. These ROCK1 data follow-up on our 53 earlier study, showing that ROCK1 activation is critical for EHV-1 infection (Frampton et al., 2007) . Future 54 studies will aim to define how ROCK1 is activated by EHV-1, what specific cellular events are reliant upon this 55 activation, and how these cellular events contribute to a productive infection. Knowledge obtained from these 56 studies may be translated into the development of antiviral compounds that can be used to inhibit the identified 57 critical processes that EHV-1 needs to complete its pathogenic program within the horse. 58
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